MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2010 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2010 Financial Results Shenzhen, China August9, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the second quarter and first half ended June30, 2010. Highlights for Second Quarter and First Half 2010]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China — May 10, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March 31, 2010. Highlights for First Quarter 2010 – Net revenues were $145.8 million, an increase of 8.7%]

MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2010 Financial Results Shenzhen,

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China — May 10, 2010 — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March 31, 2010. Highlights for First Quarter 2010 – Net revenues were $145.8 million, an increase of 8.7%]

MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2010 Financial Results Shenzhen,

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China May10, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March31, 2010. Highlights for First Quarter 2010 Net revenues were $145.8million, anrease of 8.7% over the]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China May10, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March31, 2010. Highlights for First Quarter 2010 Net revenues were $145.8million, anrease of 8.7% over the]

MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2010 Financial Results Shenzhen,

[Mindray Announces First Quarter 2010 Financial Results Shenzhen, China May10, 2010 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the first quarter ended March31, 2010. Highlights for First Quarter 2010 Net revenues were $145.8million, anrease of 8.7% over the]

MR [Mindray Medical International] 20-F: (Original Filing)

[] [LIST OF SUBSIDIARIES • Mindray (UK) Limited, incorporated in the United Kingdom • Mindray Research and Development Limited, incorporated in the British Virgin Islands • Mindray Global Limited, incorporated in the British Virgin Islands • • Shenzhen Mindray Bio-Medical Electronics Co., Ltd., incorporated in the People’s Republic of China • Beijing Shen Mindray Medical Electronics Technology Research Institute Co., Ltd.,] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ronald Ede, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION Xu Hang Chairman and Co-Chief Executive Officer Li Xiting Director, President and Co-Chief Executive Officer Ronald Ede Director, Chief Financial Officer EX-13.1 6 h04173exv13w1.htm EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-140341 on Form S-8 of our reports dated June 27, 2008, May 8, 2009 as to Note 2(x) and Note 22, relating to the 2007 consolidated financial statements (before the retrospective adjustments to the consolidated financial statements) of Mindray Medical International Limited] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-140341) and in the Registration Statement on Form F-3 (No. 333-165169) of Mindray Medical International Limited of our report dated May 7, 2010 relating to the financial statements, financial statement schedule and the effectiveness of internal control] [May 7, 2010 Dear Sirs/Madams: We have read the information required by Item 16 F of Form 20-F dated May 7, 2010 of Mindray Medical International Limited, and have the following comments: Yours sincerely, Deloitte Touche Tohmatsu CPA Ltd. EX-99.1 9 h04173exv99w1.htm EX-99.1]

MR [Mindray Medical International] 20-F: (Original Filing)

[TABLE OFNTENTS Page INTRODUCTION 3 PARTI 5 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 5 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 5 ITEM 3. KEY INFORMATION 5 ITEM 4. INFORMATION ON THEMPANY 25 ITEM 4A. UNRESOLVED STAFFMMENTS 44 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS] [LIST OF SUBSIDIARIES Mindray (UK)Limited,orporated in the United Kingdom Mindray Research and Development Limited,orporated in the British Virgin Islands Mindray Global Limited,orporated in the British Virgin Islands Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Beijing Shen Mindray Medical Electronics Technology Research Instituteorporated in the Peoples Republic of China] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Ronald Ede, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION Xu Hang Chairman and-Chief Executive Officer Li Xiting Director, President and-Chief Executive Officer Ronald Ede Director, Chief Financial Officer EX-13.1 h04173exv13w1.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No.333-140341 on Form S-8 of our reportsted June27, 2008, May8, 2009 to Note 2(x) and Note 22, relating to the 2007nsolidated financial statements (before the retrospectivejustments to thensolidated financial statements) of Mindray Medical International Limited (not presented herein) (which report] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No. 333-140341) and in the Registration Statement on FormF-3 (No.333-165169) of Mindray Medical International Limited of our reportted May7, 2010 relating to the financial statements, financial statementhedule and the effectiveness of internalntrol over financial reporting, which] [May7, 2010 Dear Sirs/Madams: We have read the information required by Item16 F of Form 20-Fted May7, 2010 of Mindray Medical International Limited, and have the followingmments: Yours sincerely, Deloitte Touche Tohmatsu CPA EX-99.1 h04173exv99w1.htm 9 EX-99.1]

MR [Mindray Medical International] 20-F: TABLE OFNTENTS Page INTRODUCTION 3 PARTI 5 ITEM

[TABLE OFNTENTS Page INTRODUCTION 3 PARTI 5 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT ANDVISERS 5 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 5 ITEM 3. KEY INFORMATION 5 ITEM 4. INFORMATION ON THEMPANY 25 ITEM 4A. UNRESOLVED STAFFMMENTS 44 ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS] [LIST OF SUBSIDIARIES Mindray (UK)Limited,orporated in the United Kingdom Mindray Research and Development Limited,orporated in the British Virgin Islands Mindray Global Limited,orporated in the British Virgin Islands Shenzhen Mindray Bio-Medical Electronicsorporated in the Peoples Republic of China Beijing Shen Mindray Medical Electronics Technology Research Instituteorporated in the Peoples Republic of China] [CERTIFICATION I, Xu Hang, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Li Xiting, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION I, Ronald Ede, certify that: 1. I have reviewed this annual report on Form 20-F of Mindray Medical International Limited; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATION Xu Hang Chairman and-Chief Executive Officer Li Xiting Director, President and-Chief Executive Officer Ronald Ede Director, Chief Financial Officer EX-13.1 h04173exv13w1.htm 6 EX-13.1] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Wensent to theorporation by reference in Registration Statement No.333-140341 on Form S-8 of our reportsted June27, 2008, May8, 2009 to Note 2(x) and Note 22, relating to the 2007nsolidated financial statements (before the retrospectivejustments to thensolidated financial statements) of Mindray Medical International Limited (not presented herein) (which report] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on FormS-8 (No. 333-140341) and in the Registration Statement on FormF-3 (No.333-165169) of Mindray Medical International Limited of our reportted May7, 2010 relating to the financial statements, financial statementhedule and the effectiveness of internalntrol over financial reporting, which] [May7, 2010 Dear Sirs/Madams: We have read the information required by Item16 F of Form 20-Fted May7, 2010 of Mindray Medical International Limited, and have the followingmments: Yours sincerely, Deloitte Touche Tohmatsu CPA EX-99.1 h04173exv99w1.htm 9 EX-99.1]

Skip to toolbar